VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
HROW
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
HROWHarrow Health, Inc.
$33.60$1.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksHROWQuarterly Financials

Harrow Health, Inc. (HROW) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Harrow Health, Inc. (HROW) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

HROW Income Statement

Quarterly statement

HROW Income Statement

Harrow Health, Inc. (HROW) annual income statement — 20-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue70.66M44.2M89.09M71.64M63.74M47.83M66.83M49.26M48.94M34.59M36.35M34.27M33.47M26.1M20.33M22.82M23.32M22.12M20.19M18.71M
Revenue Growth %10.85%-7.58%33.31%45.44%30.25%38.29%83.83%43.75%46.22%32.5%78.83%50.13%43.51%18.01%0.7%21.98%28.61%43.24%38.32%29.95%
Cost of Goods Sold20.3M17.16M18.47M17.71M16.23M15.52M14.13M12.02M12.54M10.55M11.3M10.07M10M8.27M6.17M6.72M6.53M5.96M5.08M4.95M
COGS % of Revenue28.73%38.82%20.73%24.72%25.46%32.46%21.15%24.4%25.62%30.51%31.09%29.38%29.88%31.69%30.33%29.45%28.02%26.96%25.16%26.44%
Gross Profit50.36M27.05M70.62M53.93M47.51M32.31M52.7M37.24M36.4M24.03M25.05M24.2M23.47M17.83M14.16M16.1M16.79M16.16M15.11M13.76M
Gross Margin %71.27%61.18%79.27%75.28%74.54%67.54%78.85%75.6%74.38%69.49%68.91%70.62%70.12%68.31%69.67%70.55%71.98%73.04%74.84%73.56%
Gross Profit Growth %6%-16.29%34.02%44.81%30.53%34.42%110.34%53.89%55.09%34.78%76.88%50.28%39.79%10.37%-6.25%16.99%22.4%38.41%41.75%28.6%
Operating Expenses61.37M49.13M46.58M39.18M36.1M43.54M39.8M35.92M34.87M30.96M29.93M22.45M21.12M16.62M15.94M16.2M15.1M14.06M16.86M17.48M
OpEx % of Revenue86.85%111.14%52.29%54.69%56.64%91.03%59.55%72.92%71.25%89.52%82.32%65.53%63.1%63.68%78.42%70.96%64.74%63.54%83.53%93.43%
Selling, General & Admin53.3M43.23M43.31M00000000000000000
SG&A % of Revenue75.43%97.8%48.61%-----------------
Research & Development8.07M5.89M3.27M3.32M2.87M3.03M4.75M2.27M3.05M2.15M3.34M1.42M1.16M734K703K775K914K658K3.87M6.15M
R&D % of Revenue11.42%13.34%3.67%4.64%4.5%6.33%7.12%4.61%6.24%6.21%9.18%4.15%3.47%2.81%3.46%3.4%3.92%2.97%19.16%32.85%
Other Operating Expenses0001000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income-11.01M-22.08M24.04M14.75M11.41M-11.23M12.9M1.32M1.53M-6.93M-4.88M1.74M2.35M1.21M-1.78M-94K1.69M2.1M-1.75M-3.72M
Operating Margin %-15.58%-49.95%26.98%20.59%17.9%-23.48%19.3%2.68%3.13%-20.03%-13.41%5.09%7.03%4.64%-8.75%-0.41%7.25%9.5%-8.69%-19.87%
Operating Income Growth %-196.48%-96.58%86.38%1016.35%645.69%-62.12%364.59%-24.25%-34.95%-672.56%-174.18%1955.32%39.17%-42.41%-1.31%97.47%-59.46%-27.97%-166.83%-332.75%
EBITDA-11.01M-16.5M28.82M19.31M15.98M-6.69M17.3M4.28M4.38M-4.08M-2.12M4.62M5.42M3.64M-1.07M475K2.47M2.88M-1.34M-3.27M
EBITDA Margin %-15.58%-37.32%32.35%26.96%25.07%-14%25.88%8.68%8.95%-11.79%-5.82%13.48%16.2%13.95%-5.29%2.08%10.59%13.02%-6.63%-17.47%
EBITDA Growth %-168.87%-146.43%66.64%351.55%264.89%-64.15%917.73%-7.38%-19.23%-211.97%-96.74%872.21%119.64%26.41%19.66%114.53%-45.96%-15.09%-140.36%-241.58%
D&A (Non-Cash Add-back)05.58M4.78M4.57M4.57M4.54M4.4M2.96M2.85M2.85M2.76M2.87M3.07M2.43M703K569K779K780K417K448K
EBIT-11.01M-22.08M15.58M7.06M11.4M-11.23M13.15M1.32M-347K-8.15M-4.5M1.74M2.35M1.21M-1.78M-94K1.69M2.1M-6K-3.72M
Net Interest Income-6.26M-5.5M-5.19M-6.04M-6.41M-6.55M-6.38M-5.53M-5.47M-5.42M-5.12M-5.75M-5.7M-4.75M-1.86M-1.8M-1.79M-1.79M-1.92M-1.69M
Interest Income00000000000000-00000
Interest Expense6.26M5.5M5.19M6.04M6.41M6.55M6.38M5.53M5.47M5.42M5.12M5.75M5.7M4.75M1.86M1.8M1.79M1.79M1.92M1.69M
Other Income/Expense-6.26M-5.5M-13.64M-13.73M-6.41M-6.55M-6.64M-5.52M-7.35M-6.64M-4.81M-4.6M-6.6M-8.14M2.83M-6.33M-7.89M-4.54M-5.53M-4.61M
Pretax Income-17.27M-27.58M10.4M1.02M5M-17.78M6.26M-4.2M-5.82M-13.56M-9.68M-2.85M-4.24M-6.93M1.05M-6.43M-6.2M-2.44M-7.29M-8.33M
Pretax Margin %-24.44%-62.39%11.67%1.42%7.84%-37.17%9.37%-8.53%-11.89%-39.22%-26.63%-8.32%-12.68%-26.55%5.19%-28.17%-26.58%-11.02%-36.09%-44.51%
Income Tax025K3.77M000-514K20K655K0-535K1.54M-15K-288K035K40K0133K0
Effective Tax Rate %0%-0.09%36.27%0%0%0%-8.21%-0.48%-11.26%0%5.53%-53.96%0.35%4.16%0%-0.54%-0.65%0%-1.83%0%
Net Income-17.27M-27.6M6.63M1.02M5M-17.78M6.78M-4.22M-6.47M-13.56M-9.15M-4.39M-4.23M-6.64M1.05M-6.46M-6.24M-2.44M-7.42M-8.33M
Net Margin %-24.44%-62.44%7.44%1.42%7.84%-37.17%10.14%-8.57%-13.23%-39.22%-25.16%-12.81%-12.64%-25.45%5.19%-28.32%-26.75%-11.02%-36.74%-44.51%
Net Income Growth %-445.75%-55.24%-2.23%124.17%177.17%-31.07%174.08%3.89%-53.06%-104.2%-967.11%32.07%32.22%-172.48%114.22%22.38%-151.78%-1223.5%-745.6%-196.41%
Net Income (Continuing)-17.27M-27.6M6.63M1.02M5M-17.78M6.78M-4.22M-6.47M-13.56M-9.15M-4.39M-4.23M-6.64M1.05M-6.46M-6.24M-2.44M-7.42M-8.33M
Discontinued Operations00000000000000000000
Minority Interest-355K-355K-355K-355K-355K-355K-355K-355K-355K-355K-355K-355K-355K-355K-355K-355K-355K-355K-355K-355K
EPS (Diluted)-0.46-0.740.180.030.13-0.500.19-0.12-0.18-0.38-0.26-0.13-0.14-0.220.04-0.24-0.23-0.09-0.27-0.31
EPS Growth %-453.85%-48%-5.26%121.83%172.22%-31.58%173.08%7.69%-28.57%-72.73%-826.26%45.83%39.13%-144.44%113.26%22.58%-109.09%-1000%-775%-196.88%
EPS (Basic)-0.46-0.740.180.030.14-0.500.19-0.12-0.18-0.38-0.26-0.13-0.14-0.220.04-0.24-0.23-0.09-0.27-0.31
Diluted Shares Outstanding37.35M37.23M36.76M38.88M38.85M35.83M35.81M35.7M35.62M35.47M35.35M34.26M30.46M30.29M29.43M27.35M27.3M27.23M27.47M27.11M
Basic Shares Outstanding37.35M37.23M36.76M37.15M36.79M35.83M35.81M35.7M35.62M35.47M35.35M34.26M30.46M30.29M27.96M27.35M27.3M27.09M27.47M27.11M
Dividend Payout Ratio--------------------